alpha-tocotrienol quinone: Clinical Trials

2 trials of alpha-tocotrienol quinone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow alpha-tocotrienol quinone: new trials by email Literature Review of alpha-tocotrienol quinone trials Research Report on alpha-tocotrienol quinone

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Trial of EPI-743 for Adults With Tourette Syndrome
EPI-743 - Tourette Syndrome
Phase 1CompletedYale University102012-10-012014-03-05
EPI-743 for Metabolism or Mitochondrial Disorders
EPI-743, Placebo - Mitochondrial Disease, Neurology
Phase 1 / Phase 2CompletedNational Human Genome Research Institute (NHGRI)202012-09-012021-04-14

Conditions studied

Mitochondrial Diseases (1)  ·  Muscular Diseases (1)  ·  Tic Disorders (1)  ·  Tics (1)  ·  Tourette Syndrome (1)

Sponsors

National Human Genome Research Institute (NHGRI) (1)  ·  Yale University (1)

Countries

United States (2)

Top investigators

Michael H Bloch, MD, MS (1)  ·  William A Gahl, M.D. (1)